Carl Ashley Morris is CSO at Solid Biosciences Inc. (SLDB). They have made 3 open-market trades across 1 company since 2020, most recently 2023-01-27.
CIK 0001727571
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SLDB | 20,201 | $132K |
Shares reported on the most recent Form 4, priced at the 2023-01-31 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SLDB | SELL · 10b5-1 | 2023-01-27 | 2023-01-31 | $7.49 | $3K | -7.7% | -28.8% | -29.8% |
| SLDB | SELL · 10b5-1 | 2022-03-14 | 2022-03-15 | $1.10 | $25K | +20.2% | +1.0% | -38.0% |
| SLDB | SELL | 2021-03-12 | 2021-03-15 | $8.84 | $414K | -28.2% | -34.7% | -49.4% |
| SLDB | SELL | 2021-01-28 | 2021-01-29 | $6.14 | $21K | +25.3% | +30.7% | -20.6% |
| SLDB | SELL | 2020-07-28 | 2020-07-29 | $2.42 | $9K | +10.7% | -2.9% | +38.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.